Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022003
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-08-28
Brief Title:
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects 18 Years of Age With RelapsedRefractory FLT3-mutated Acute Myeloid Leukemia
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Organization Data
Organization:
French Innovative Leukemia Organisation
Class:
OTHER
Study ID:
FILOAML-RR-01 OGILAR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French Innovative Leukemia Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Acute Leukemia French Association | OTHER |